In 2019, the first gene therapy treatment for a neurogenetic disease was approved for SMA. This therapy is just the beginning, and it’s marked a tipping point in genomic analysis as it reshapes the field of neurology.
Radiation May Lower Potential for Side Effects of CAR T Therapy in Non-Hodgkin’s Lymphoma
Electric Pill Bottles and Text Messaging Not Enough to Affect Blood Pressure Control
Penn’s Angela DeMichele, MD, MSCE Part of Team Awarded Stand Up 2 Cancer Grant
Penn’s Basser Center for BRCA Chooses Two Cambridge Researchers for 2019 Basser Global Prize
This Med Student Was Given Last Rites Before Finding a Treatment That Saved His Life; His Method Could Help Millions
Hepatitis C-Infected Kidneys Are Safe and Work as Well as Uninfected Organs, Study Finds
Hepatitis C-Infected Kidneys Function as Well as Others After Transplant, Study Says
CRISPR Gene-Editing Shows Promise as HIV Cure, Research Shows
U.S. Throws Away 3,500 Donated Kidneys Per Year, Study Says
Flavored E-Cigarettes More Likely to Turn Youth into Regular Users, Study Finds